Zdrowie i gospodarka · 1.02.2012
Food and Drug Administration Transparency Initiative: Exploratory Program To Increase Access to the Agency's Compliance and Enforcement Data; Availability
The Food and Drug Administration (FDA) is announcing the availability of a report entitled "Food and Drug Administration Transparency Initiative: Exploratory Program to Increase Access to the Agency's Compliance and Enforcement Data," as part of the Transparency Initiative. This report includes eight initiatives adopted by the Commissioner of Food and Drugs (the Commissioner) to explore avenues for making FDA's publicly available compliance and enforcement data more accessible and user-friendly.